Publication number: 20180208660
Abstract: The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.
Type:
Application
Filed:
March 14, 2018
Publication date:
July 26, 2018
Applicant:
PharmAbcine Inc.
Inventors:
Joong Kyu Kim, Jin San Yoo, Sang Hoon Lee, Weon Sup Lee, Sung Woo Kim, Sang Ryeol Shim, Jin Sang Yoo, Young Ae Lee, Mi Ju Park, Sang Soon Byun, Hyuk Joon Lee, Do Yun Kim, Yeun Ju Kim, Jin Hee Choi, Kyung Hee Nahm, Ju Ryung Nam, Jong Geun Jeong, Bo Young Jeong, Eun Jin Lee, Seon Young Lee, In Sook Park, Jin Sook Lee, Jae Bong Yoon, Nam Ye Kim, Seon Hwan Oh
Publication number: 20150315277
Abstract: The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.
Type:
Application
Filed:
November 20, 2013
Publication date:
November 5, 2015
Applicant:
PharmAbcine Inc.
Inventors:
Joong Kyu Kim, Jin San Yoo, Sang Hoon Lee, Weon Sup Lee, Sung Woo Kim, Sang Ryeol Shim, Jin Sang Yoo, Young Ae Lee, Mi Ju Park, Sang Soon Byun, Hyuk Joon Lee, Do Yun Kim, Yeun Ju Kim, Jin Hee Choi, Kyung Hee Nahm, Ju Ryung Nam, Jong Geun Jeong, Bo Young Jeong, Eun Jin Lee, Seon Young Lee, In Sook Park, Jin Sook Lee, Jae Bong Yoon, Nam Ye Kim, Seon Hwan Oh